Adjuvant Therapy for Older Women with Early-Stage Breast Cancer: Treatment Selection in a Complex Population T1ab N0 breast cancer generally has excellent prognosis. Adverse prognostic factors include ...
Of 15 IRs, 47% were locoregional only. Among T1ab patients not treated with adjuvant trastuzumab or chemotherapy (n = 171), the 5-year invasive DRFI was 98.2% (95% CI, 94.5% to 99.4%); it was 99.0% ...
In the past decade, the incidence of T1a/b prostate cancer has remained stable, but clinically significant T1a/b disease has increased over time. Across all risk groups and accounting for age and ...
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced new data supporting the clinical utility of its DecisionDx-Melanoma and DecisionDx-SCC ...
Among patients with T1a cutaneous melanomas, younger age and tumors in the head/neck region were most likely to demonstrate sentinel lymph node positivity, according to a study. “Sentinel lymph node ...
In a population-based study, PN was associated with improved cancer-specific survival by 56%. Partial nephrectomy (PN) is the optimal surgical approach for T1a renal cell carcinoma (RCC), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback